To identify alterations in gene expression and methylation markers induced by the ex vivo treatment of peripheral blood mononuclear cells from symptomatic patients with treatment-resistant depression with ketamine and assess their correlations with clinical response (as measured by the reduction in the Hamilton Depression Rating Scale - HDRS). For that end blood samples will be collected from all subjects immediately before the first administration of ketamine.